ISTH 2020 Congress
Coagulation and Natural Anticoagulants
Theme Navigation
Abstract Number: PB0154
Activated recombinant Factor VII (rFVIIa) Inhibitor in Iran: Immunogenicity is a Major Challenge through Treated Bleeds Covered with rFVIIa
Abstract Number: PB0249
Activation of Coagulation by 5.8S RNA
Abstract Number: PB0394
Acute Deep Vein Thrombosis Is Associated with Increased Platelet Thrombin Generation and Increased Procoagulant Oxidised Phosphatidylethanolamine
Abstract Number: PB0360
ADAMTS-13/VWF as Biomarker for Portal Vein Thrombosis Development in Cirrhotic Patients: A Prospective Study
Abstract Number: PB0227
Addition of Histone Deacetylase Inhibitors Increases Recombinant Factor V Expression in BHK Cells
Abstract Number: PB0368
Adhesive Properties of Plasma-Circulating and Platelet-Derived Microvesicles
Abstract Number: PB0241
Allosteric Modulation of Exosite 1 Attenuates the Enhancing Effect of Polyphosphate on FXI Activation by Thrombin
Abstract Number: PB0239
Always Ask Relevant Questions to Patients Might Be They Tell You the Diagnosis
Abstract Number: PB0343
An Overview of Patients with Hemophilia A in China: Epidemiology, Disease Severity, and Treatment Strategies
Abstract Number: PB0348
Analytical Variability (CV) of One Stage Factor VIII Assay: A Quality Control (QC) Experience. Argentinian Group of Biochemists in Hemophilia
Abstract Number: PB0124
Anti-Aggregant Effect of Butanolic Extract of Rubia Tinctorum on Platelets in vitro and ex vivo
Abstract Number: PB0226
Anti-factor V Inhibitor after Liver Transplantation
Abstract Number: PB0424
Anticoagulant Activity in Unclassified Bleeding Disorders
Abstract Number: PB0213
Anticoagulant Effect of Novel Nanoparticles Functionalized with Synthetic Piperazinone Derivatives as FXa Inhibitors
Abstract Number: PB0182
Anticoagulant Effects of Parenteral Sulodexide as Measured by Activated Clotting Time. Relevance to Dosing in Various Indications
Abstract Number: PB0166
Anticoagulation with the Novel, Small-molecule Factor XIa (fXIa) Antagonist, EP-7041, Prevents Oxygenator Clotting but Conserves Hemostasis in a Canine Extracorporeal Circulation (ECMO) Model
Abstract Number: PB0179
Antithrombotic Effects of a Novel Small Molecular Fxia Inhibitor BMS-986177/JNJ-70033093 in a Rabbit AV-Shunt Model of Thrombosis
Abstract Number: PB0144
Antithrombotic Properties of Carvedilol Shown in Two Independent Intravital Real Time Models of Thrombosis
Abstract Number: PB0361
APML: 2 Cases of Discordant Coagulation Results and ROTEM Testing
Abstract Number: PB0339
aPTT Reaction Curves Provide Important Additional Information in Hemophilia Patients